Skip to content
drillr.ai
Sign up

IMRN

Immuron Limited

NASDAQ · Healthcare · Biotechnology · AU

$1.80
+62.16%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue12.6M7.5M7.3M4.9M1.8M
Cost of Revenue4.5M2.7M2.5M1.6M64.6K
Gross Profit8.1M4.9M4.8M3.3M1.7M
Operating Expenses
R&D Expense3.6M—3.6M5.4M2.6M
SG&A Expense13.9M7.6M7.9M6.6M5.1M
General & Admin Expense3.3M—4.5M4.6M4.2M
Selling & Marketing Expense2.8M—3.5M2.0M927.4K
Other Expenses(364.4K)1.9M(1.4M)(2.8M)(2.4M)
Total Operating Expenses17.1M9.5M10.1M9.1M5.3M
Cost and Expenses21.6M12.2M12.6M10.7M5.4M
Operating Income (EBIT)(9.0M)(4.6M)(5.3M)(5.8M)(3.6M)
Non-Operating
Interest Income177.4K—135.9K327.8K116.3K
Interest Expense14.7K14.4K7.3K7.6K9.7K
Net Interest Income162.7K(14.4K)128.6K320.2K106.7K
Other Non-Op Income/Expense396.2K267.2K128.6K(1.1M)(217.7K)
Non-Operating Income (excl Interest)50.2K—12.2K(585.3K)(159.9K)
EBT (Pre-Tax Income)(8.6M)(4.4M)(5.2M)(6.9M)(3.8M)
Income Tax Expense(618.5K)(610.0K)———
Bottom Line
Net Income(8.0M)(3.8M)(5.2M)(6.9M)(3.8M)
Earnings from Cont. Ops(8.0M)(3.8M)(5.2M)(6.9M)(3.8M)
Earnings from Discont. Ops—————
Bottom Line Net Income(8.0M)(3.8M)(5.2M)(6.9M)(3.8M)
Per Share
Basic EPS($1.21)($0.50)($0.90)($1.22)($0.66)
Diluted EPS($1.21)($0.50)($0.90)($1.22)($0.66)
Revenue Per Share$1.55$1.01$1.26$0.86$0.32
Shares
Basic Shares Outstanding8.1M7.4M5.8M5.7M5.7M
Diluted Shares Outstanding8.1M7.4M5.8M5.7M5.7M
Profitability Metrics
EBITDA(9.0M)(4.6M)(5.3M)(5.2M)(3.4M)
D&A14.5K—49.7K46.0K48.7K
EBIT(9.0M)(4.6M)(5.4M)(5.2M)(3.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026